_version_ 1783655345795629056
author Afshinnekoo, Ebrahim
Bhattacharya, Chandrima
Burguete-García, Ana
Castro-Nallar, Eduardo
Deng, Youping
Desnues, Christelle
Dias-Neto, Emmanuel
Elhaik, Eran
Iraola, Gregorio
Jang, Soojin
Łabaj, Paweł P
Mason, Christopher E
Nagarajan, Niranjan
Poulsen, Michael
Prithiviraj, Bharath
Siam, Rania
Shi, Tieliu
Suzuki, Haruo
Werner, Johannes
Zambrano, Maria Mercedes
Bhattacharyya, Malay
author_facet Afshinnekoo, Ebrahim
Bhattacharya, Chandrima
Burguete-García, Ana
Castro-Nallar, Eduardo
Deng, Youping
Desnues, Christelle
Dias-Neto, Emmanuel
Elhaik, Eran
Iraola, Gregorio
Jang, Soojin
Łabaj, Paweł P
Mason, Christopher E
Nagarajan, Niranjan
Poulsen, Michael
Prithiviraj, Bharath
Siam, Rania
Shi, Tieliu
Suzuki, Haruo
Werner, Johannes
Zambrano, Maria Mercedes
Bhattacharyya, Malay
author_sort Afshinnekoo, Ebrahim
collection PubMed
description
format Online
Article
Text
id pubmed-7906697
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-79066972021-02-26 COVID-19 drug practices risk antimicrobial resistance evolution Afshinnekoo, Ebrahim Bhattacharya, Chandrima Burguete-García, Ana Castro-Nallar, Eduardo Deng, Youping Desnues, Christelle Dias-Neto, Emmanuel Elhaik, Eran Iraola, Gregorio Jang, Soojin Łabaj, Paweł P Mason, Christopher E Nagarajan, Niranjan Poulsen, Michael Prithiviraj, Bharath Siam, Rania Shi, Tieliu Suzuki, Haruo Werner, Johannes Zambrano, Maria Mercedes Bhattacharyya, Malay Lancet Microbe Comment The Author(s). Published by Elsevier Ltd. 2021-04 2021-02-24 /pmc/articles/PMC7906697/ /pubmed/33655229 http://dx.doi.org/10.1016/S2666-5247(21)00039-2 Text en © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Afshinnekoo, Ebrahim
Bhattacharya, Chandrima
Burguete-García, Ana
Castro-Nallar, Eduardo
Deng, Youping
Desnues, Christelle
Dias-Neto, Emmanuel
Elhaik, Eran
Iraola, Gregorio
Jang, Soojin
Łabaj, Paweł P
Mason, Christopher E
Nagarajan, Niranjan
Poulsen, Michael
Prithiviraj, Bharath
Siam, Rania
Shi, Tieliu
Suzuki, Haruo
Werner, Johannes
Zambrano, Maria Mercedes
Bhattacharyya, Malay
COVID-19 drug practices risk antimicrobial resistance evolution
title COVID-19 drug practices risk antimicrobial resistance evolution
title_full COVID-19 drug practices risk antimicrobial resistance evolution
title_fullStr COVID-19 drug practices risk antimicrobial resistance evolution
title_full_unstemmed COVID-19 drug practices risk antimicrobial resistance evolution
title_short COVID-19 drug practices risk antimicrobial resistance evolution
title_sort covid-19 drug practices risk antimicrobial resistance evolution
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906697/
https://www.ncbi.nlm.nih.gov/pubmed/33655229
http://dx.doi.org/10.1016/S2666-5247(21)00039-2
work_keys_str_mv AT afshinnekooebrahim covid19drugpracticesriskantimicrobialresistanceevolution
AT bhattacharyachandrima covid19drugpracticesriskantimicrobialresistanceevolution
AT burguetegarciaana covid19drugpracticesriskantimicrobialresistanceevolution
AT castronallareduardo covid19drugpracticesriskantimicrobialresistanceevolution
AT dengyouping covid19drugpracticesriskantimicrobialresistanceevolution
AT desnueschristelle covid19drugpracticesriskantimicrobialresistanceevolution
AT diasnetoemmanuel covid19drugpracticesriskantimicrobialresistanceevolution
AT elhaikeran covid19drugpracticesriskantimicrobialresistanceevolution
AT iraolagregorio covid19drugpracticesriskantimicrobialresistanceevolution
AT jangsoojin covid19drugpracticesriskantimicrobialresistanceevolution
AT łabajpawełp covid19drugpracticesriskantimicrobialresistanceevolution
AT masonchristophere covid19drugpracticesriskantimicrobialresistanceevolution
AT nagarajanniranjan covid19drugpracticesriskantimicrobialresistanceevolution
AT poulsenmichael covid19drugpracticesriskantimicrobialresistanceevolution
AT prithivirajbharath covid19drugpracticesriskantimicrobialresistanceevolution
AT siamrania covid19drugpracticesriskantimicrobialresistanceevolution
AT shitieliu covid19drugpracticesriskantimicrobialresistanceevolution
AT suzukiharuo covid19drugpracticesriskantimicrobialresistanceevolution
AT wernerjohannes covid19drugpracticesriskantimicrobialresistanceevolution
AT zambranomariamercedes covid19drugpracticesriskantimicrobialresistanceevolution
AT bhattacharyyamalay covid19drugpracticesriskantimicrobialresistanceevolution
AT covid19drugpracticesriskantimicrobialresistanceevolution